Frankfurt | Reuters – Agriculture and pharmaceuticals company Bayer BAYGn.DE on Thursday lifted its 2022 earnings guidance on strong demand from farmers for its seeds and crop chemicals and higher sales of consumer health products. Bayer is now targeting earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for special items, of about 13 billion			
		
	Bayer’s agriculture unit, consumer health drive outlook hike
	Supreme Court asks U.S. government for views on Roundup case
								Washington | Reuters — The U.S. Supreme Court on Monday asked President Joe Biden’s administration for its views on whether the justices should hear Bayer’s bid to dismiss claims by customers who contend its Roundup herbicide causes cancer, as the company seeks to avoid potentially billions of dollars in damages. Bayer in August filed a			
		Bayer expects earnings growth on agriculture
New ag products are expected to spur ‘above-market’ growth next year
								Reuters – Germany’s Bayer on March 10 pledged to revive growth in adjusted earnings by 2024, helped by the launch of products such as digital farming services, soy seeds and non-prescription remedies. The agriculture and pharmaceuticals group said in a statement it was aiming for core earnings per share of between seven and 7.50 euros (C$10.53-$11.28) by 2024,			
		
	Bayer takes major writedown, flags Roundup settlement bill
Company writes down agribusiness assets
								Frankfurt | Reuters — Bayer is facing a double hit from a higher legal bill for claims relating to weedkiller Roundup as well as 9.25 billion euros (C$14.2 billion) in impairments on agriculture businesses, much of it related to its Monsanto deal. The company said the write-downs, driven by weaker demand from farmers due to			
		
	Bayer books second-quarter loss after settlement
								Frankfurt | Reuters — German drugs and pesticides group Bayer reported a 9.5 billion-euro (C$14.86 billion) net loss for its second quarter, following a US$10.9 billion settlement of U.S. lawsuits claiming that its Roundup herbicide caused cancer. The charges stemmed mainly from agreements which attempted to wrap up legal disputes inherited with its US$63 billion			
		
	BASF says dividends, asset values under review as pandemic bites
								Frankfurt | Reuters – Germany’s BASF said on Wednesday its dividend policy and the value of assets on its balance sheet might be revised given uncertainty caused by the coronavirus crisis, particularly in North America and Europe. The policy of the world’s largest chemicals and plastics maker by sales to increase dividends each year and			
		
	Court blocks sales of dicamba in U.S.
Bayer says it's seeking new EPA registration for 2021
								Updated — Reuters — A U.S. appeals court has blocked Bayer from selling an agricultural weed killer in the United States, the latest setback for a business already fighting an expensive legal battle over another product. A three-judge panel of the Ninth U.S. Circuit Court of Appeals ruled the U.S. Environmental Protection Agency (EPA) substantially			
		
	Bayer reporting progress in Roundup settlement talks
								Frankfurt | Reuters — Bayer said on Monday it had made progress seeking a settlement over claims its glyphosate-based Roundup herbicide causes cancer, after Bloomberg reported the company reached a verbal agreement on about 50,000 to 85,000 cases. The drugs and pesticides group is keen to draw a line under the legal dispute, which it			
		
	Pressure on for Bayer CEO to fix legal problems as chairman quits
								Frankfurt | Reuters — The departure of Bayer chairman Werner Wenning will turn up the heat on CEO Werner Baumann to resolve the healthcare to agriculture group’s legal problems, two of the firm’s biggest German shareholders said on Wednesday. Bayer’s shares have plunged about a quarter in value since August 2018, when the company lost			
		
	Bayer considers new tactic in Roundup settlement talks
								Reuters — As Bayer tries to settle U.S. lawsuits claiming that its Roundup herbicide causes cancer, the company is considering a proposal that would bar plaintiffs’ lawyers involved in the litigation from advertising for new clients, according to a person familiar with the matter. Bayer has said it is engaged in mediation to resolve the